Daily non-political popular news in brief.

IMRT better for sparing bladder when treating prostate cancer

When treating early-stage prostate cancer, intensity modulated radiation therapy spares the bladder significantly more from direct radiation when compared to 3-D conformal proton therapy , but the amount of rectal sparing is similar with both treatments, according to a study released in the October issue of the International Journal for Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.

Read more »

Keywords: imrt, sparing, bladder, treating, prostate, cancer

« Previous | Next »

Similar news on "IMRT better for sparing bladder when treating prostate cancer":

1. Biomedical engineers use electric pulses to destroy cancer cells
   07-05-2007 · EurekAlert!
   A team of biomedical engineers at Virginia Tech and the University of California at Berkeley has developed a new minimally invasive method of treating cancer, and they anticipate clinical trials on individuals with prostate cancer will begin soon.
   Similar news · Read more »
   
2. Drug slows prostate tumor growth by keeping vitamin A active
   11-06-2007 · EurekAlert!
   A novel compound that blocks the breakdown of retinoic acid, derived from vitamin A, is a surprisingly effective and "promiscuous" agent in treating animal models of human prostate cancer, say investigators from the University of Maryland, Baltimore.
   Similar news · Read more »
   
3. Patients report fewer moderate and serious side effects with IMRT than with brachytherapy
   11-07-2006 · EurekAlert!
   In one of the first studies to compare side effects of IMRT and permanent prostate brachytherapy (I-125) for treatment of low-risk prostate cancer, researchers say patients had fewer moderate and serious side effects when treated with IMRT.
   Similar news · Read more »
   
4. Treating prostate cancer in elderly men associated with longer survival, compared to non-treatment
   12-12-2006 · EurekAlert!
   New findings from an observational study suggest that elderly men who received treatment for localized prostate cancer survived significantly longer than men who did not receive treatment, according to a study in the December 13 issue of JAMA; however, the investigators emphasize the importance of validating these results in randomized trials.
   Similar news · Read more »
   
5. IMRT versus 3D CRT for prostate cancer, new long-term data assesses side effects
   11-05-2006 · EurekAlert!
   New research findings show men have fewer long-term gastrointestinal side effects with intensity-modulated radiation therapy (IMRT) than with three-dimensional conformal radiation therapy (3D CRT) for prostate cancer treatment, despite the higher doses of radiation used in the IMRT group. These and other data, including long-term genitourinary side effects, were presented today.
   Similar news · Read more »
   
6. Integrated approach to radiation therapy provides quality care for cancer patients
   11-07-2006 · EurekAlert!
   Results from a University of Pittsburgh study demonstrate that intensity-modulated radiation therapy (IMRT) can be uniformly delivered in a large health care system of academic and community cancer centers through a centralized planning and treatment process. According to study results, there were no significant differences in toxicity profiles and recommended radiation dose prescriptions in 758 prostate cancer patients treated with IMRT at 12 separate community cancer centers and one academic flagship facility.
   Similar news · Read more »
   
7. Adding radiation therapy for treatment of advanced prostate cancer may offer benefit
   11-14-2006 · EurekAlert!
   Treating advanced prostate cancer with radiation therapy after removal of the prostate gland reduces the risk of disease recurrence, but does not appear to significantly improve the length of survival, according to a study in the Nov. 15 issue of JAMA, a theme issue on men's health.
   Similar news · Read more »
   
8. Animal study identifies promising new target for brain tumor therapy
   05-08-2007 · EurekAlert!
   A drug that targets the body's immune cells may be effective in treating malignant brain tumors, according to a new study led by researchers from Duke's Preston Robert Tisch Brain Tumor Center. In animal models, the drug re-engaged the body's cancer-damaged immune system.
   Similar news · Read more »
   
9. Innovative device to treat brain cancer shows promise in early studies
   05-29-2007 · EurekAlert!
   New early data showed that an investigational device that specifically targets rapidly growing cancer cells with intermediate frequency electrical fields -- called Tumor-Treating Fields -- more than doubled the median overall survival rates in patients with recurrent glioblastoma multiforme, the most common and aggressive type of malignant brain tumor.
   Similar news · Read more »
   
10. Lilly studies try to shed light on impact of race
    06-01-2007 · EurekAlert!
    Researchers at Eli Lilly and Company are actively investigating the efficacy and safety of lung cancer treatments ALIMTA (pemetrexed for injection) and GEMZAR (gemcitabine HCl for injection) in treating non-small cell lung cancer in African-Americans, Hispanics and other diverse populations.
    Similar news · Read more »